versión imprimible
 
 

Gene Therapy for Muscular Disorders

Evvnt Promotion / evvnt
-
25.05.2021 - 27.05.2021  Online
Time: 08:00 to 17:00
 
Temas de la conferencia
With clinical holds lifting there has been more investment and clinical progress in the gene therapy for muscular disorders space than ever before, yet the consequences of toxicity are not a distant memory. Despite the successes, there are still withstanding challenges for gene therapy developers targeting the muscle when it comes to optimizing delivery and navigating toxicity to develop truly safe and transformative therapeutics for muscular disorders patients.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/727634-0?pid=4832

Speakers: Michael O'Callaghan, Senior Vice President, Translational Medicine, AskBio, Michael Roberts, Chief Technology Officer, AskBio Europe, and more.
 

Información e inscripción:

https://go.evvnt.com/727634-1?pid=4832
Mr. Ellie Saunders
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 1199.00 to USD 2696.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioEuropean Public Health Association (EUPHA)Österreichische Gesellschaft für Public HealthCenter of ExcellenceCharité International AcademyOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation AGEM - Arbeitsgemeinschaft Ethnologie und MedizinAlumni Club Medizinische Universität Wien